SIR-Spheres: Completed Phase III enrollment

Sirtex said investigators completed enrollment of >=360 patients in the open-label, international

Read the full 122 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE